tiprankstipranks
Trending News
More News >
Cedar. Co.,Ltd (JP:2435)
:2435
Japanese Market

Cedar. Co.,Ltd (2435) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Cedar. Co.,Ltd

(2435)

Rating:69Neutral
Price Target:
¥234.00
▲(9.35%Upside)
Cedar Co., Ltd's stock is bolstered by strong valuation metrics, including an attractive P/E ratio and high dividend yield, making it appealing for value and income investors. Financial performance shows growth and improving profit margins, though high leverage and reliance on debt financing remain concerns. Technical indicators are mixed, with some bearish signals offset by positive MACD momentum. Overall, the stock presents opportunities but comes with notable financial stability risks.

Cedar. Co.,Ltd (2435) vs. iShares MSCI Japan ETF (EWJ)

Cedar. Co.,Ltd Business Overview & Revenue Model

Company DescriptionCedar Co., Ltd (2435) operates primarily in the healthcare and wellness sector, focusing on providing comprehensive care services for the elderly. The company offers a range of services including in-home care, day services, and residential care facilities, aiming to improve the quality of life for seniors. Cedar Co., Ltd is committed to fostering a supportive environment for both its clients and employees, ensuring high standards of care and professionalism.
How the Company Makes MoneyCedar Co., Ltd generates revenue through the provision of its various eldercare services. The company's primary revenue streams include fees charged for in-home care services, enrollment and participation fees for day service programs, and payments for long-term residential care in its facilities. Additionally, Cedar Co., Ltd may receive government subsidies and insurance payments that support its operations. Strategic partnerships with medical professionals and healthcare organizations also contribute to its financial stability, enabling the company to offer comprehensive and integrated care solutions.

Cedar. Co.,Ltd Financial Statement Overview

Summary
Cedar Co., Ltd shows promising growth with improving revenue and profit margins. However, high leverage poses a risk, although effective capital utilization is evident with a strong ROE. Cash flow is strengthening, but reliance on debt financing could be concerning if not managed properly.
Income Statement
72
Positive
The company exhibits steady revenue growth over the past years, with a 2.9% growth in the latest period. Gross profit margin is healthy at 12.8%, and net profit margin has improved to 2.0%, indicating enhanced profitability. However, EBIT and EBITDA margins show modest improvement, which suggests room for operational efficiency enhancements.
Balance Sheet
65
Positive
The balance sheet reflects high leverage with a debt-to-equity ratio of 10.42, raising concerns about financial stability. Despite this, the return on equity improved to 25.1%, highlighting effective capital utilization. The equity ratio at 7.0% is low, suggesting that the company is heavily reliant on debt financing.
Cash Flow
68
Positive
Operating cash flow is positive and covers net income well with a ratio of 2.23. Free cash flow growth is volatile but has improved, showing a positive trajectory at 46.5% from the previous year. However, the free cash flow to net income ratio is relatively low, indicating that net income conversion to free cash is not optimal.
Breakdown
TTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income StatementTotal Revenue
17.76B17.83B17.30B16.44B15.75B15.61B
Gross Profit
2.34B2.29B2.21B1.59B1.55B2.07B
EBIT
887.00M893.00M767.00M136.00M193.00M809.00M
EBITDA
1.25B1.66B1.45B935.00M728.00M1.47B
Net Income Common Stockholders
224.00M348.00M203.00M-276.00M-319.00M387.00M
Balance SheetCash, Cash Equivalents and Short-Term Investments
1.72B1.48B1.64B1.03B796.00M825.00M
Total Assets
20.13B19.91B20.33B20.25B20.46B19.56B
Total Debt
14.64B14.47B15.22B15.63B15.84B14.76B
Net Debt
12.92B12.99B13.58B14.61B15.04B13.93B
Total Liabilities
18.70B18.50B19.24B19.36B19.30B17.95B
Stockholders Equity
1.42B1.39B1.08B889.00M1.16B1.61B
Cash FlowFree Cash Flow
0.00295.00M995.00M394.00M-984.00M-876.00M
Operating Cash Flow
0.00777.00M1.47B797.00M513.00M1.14B
Investing Cash Flow
0.00-142.00M-446.00M-358.00M-1.47B-2.06B
Financing Cash Flow
0.00-791.00M-418.00M-207.00M928.00M881.00M

Cedar. Co.,Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price214.00
Price Trends
50DMA
216.70
Negative
100DMA
221.69
Negative
200DMA
215.25
Negative
Market Momentum
MACD
-2.39
Positive
RSI
48.05
Neutral
STOCH
28.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2435, the sentiment is Negative. The current price of 214 is below the 20-day moving average (MA) of 224.90, below the 50-day MA of 216.70, and below the 200-day MA of 215.25, indicating a bearish trend. The MACD of -2.39 indicates Positive momentum. The RSI at 48.05 is Neutral, neither overbought nor oversold. The STOCH value of 28.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2435.

Cedar. Co.,Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥2.52B6.58
4.00%5.85%-22.29%
75
Outperform
¥3.05B9.58
3.11%4.85%4759.88%
72
Outperform
¥3.02B8.08
2.51%2.33%-0.96%
69
Neutral
¥2.41B6.95
2.79%3.03%70.93%
64
Neutral
¥5.93B2.90
3.26%0.91%857.08%
58
Neutral
¥5.34B12.20
3.53%10.13%
54
Neutral
$5.38B3.40-45.06%3.28%16.75%-0.02%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2435
Cedar. Co.,Ltd
216.00
8.54
4.12%
JP:2373
Care Twentyone Corporation
399.00
-74.53
-15.74%
JP:2425
Care Service Co., Ltd.
801.00
-43.36
-5.14%
JP:6059
Uchiyama Holdings Co., Ltd.
307.00
-25.85
-7.77%
JP:7129
Miahelsa Holdings Corporation
1,092.00
66.96
6.53%
JP:9220
FB CARE SERVICE CO.,LTD.
997.00
29.83
3.08%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.